Published in Hepatology on April 01, 1996
Long term effect of alpha interferon in children with chronic hepatitis B. Gut (2000) 2.21
Reviews for APASL guidelines: immunomodulator therapy of chronic hepatitis B. Hepatol Int (2008) 0.92
A dose ranging study of the pharmacokinetics, safety, and preliminary efficacy of lamivudine in children and adolescents with chronic hepatitis B. Antimicrob Agents Chemother (2000) 0.90
Natural history and clinical management of chronic hepatitis B virus infection in children. Hepatol Int (2008) 0.88
Interferon-alpha2b therapy is efficacious in Asian-Americans with chronic hepatitis B infection: a prospective controlled trial. Dig Dis Sci (1998) 0.85
Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha. World J Gastroenterol (2006) 0.84
Histological outcome of chronic hepatitis B in children treated with interferon alpha. World J Gastroenterol (2005) 0.78
Vitamin E treatment for children with chronic hepatitis B: a randomized placebo controlled trial. World J Gastroenterol (2008) 0.76
Hepatitis B in childhood: An update for the paediatrician. Paediatr Child Health (2001) 0.75
Pediatric hepatitis B treatment. Ann Transl Med (2017) 0.75
A receptor in pituitary and hypothalamus that functions in growth hormone release. Science (1996) 5.45
Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med (1997) 3.71
A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet (1998) 3.33
Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol (1982) 3.09
Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med (1980) 2.41
Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. Gastroenterology (1993) 2.32
Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. J Pediatr (1993) 2.32
Long term effect of alpha interferon in children with chronic hepatitis B. Gut (2000) 2.21
Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen. Lancet (1993) 2.09
Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology (1980) 2.04
'Pure' invasive apocrine carcinoma of the breast: a new clinicopathological entity? Breast (2005) 1.99
Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet (1974) 1.97
Autoimmune hepatitis in childhood: a 20-year experience. Hepatology (1997) 1.97
Association between HLA and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr (1993) 1.96
A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock. Chest (1999) 1.91
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology (1985) 1.86
Hepatocellular carcinoma in primary biliary cirrhosis: report of four cases. Gut (1979) 1.83
Poor bone quality or hip structure as risk factors affecting survival of total-hip arthroplasty. Lancet (2000) 1.82
Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage. Q J Med (1975) 1.82
Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period. J Hepatol (1998) 1.79
Fetal ascites: an unusual presentation of Niemann-Pick disease type C. Arch Dis Child (1989) 1.77
Biliary atresia: the King's College Hospital experience (1974-1995) J Pediatr Surg (1997) 1.75
Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis. Gut (1978) 1.73
Hepatic 'stem cell' malignancies in adults: four cases. Histopathology (2003) 1.73
Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet (1987) 1.68
Sentinelle traces of an epidemic of acute gastroenteritis in France. Lancet (1995) 1.67
Hepatitis C virus infection and related liver disease in children of mothers with antibodies to the virus. J Pediatr (1997) 1.64
Recurrence of primary biliary cirrhosis after liver transplantation. N Engl J Med (1982) 1.64
Lymphocyte cytotoxicity for isolated hepatocytes in alcoholic liver disease. Gastroenterology (1977) 1.61
Jaundice at 14 days of age: exclude biliary atresia. Arch Dis Child (1991) 1.61
Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet (1988) 1.60
Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology (2001) 1.59
Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. AIDS (1996) 1.59
Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis. Gastroenterology (1997) 1.58
Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers. Q J Med (1989) 1.57
Posttransfusion and community-acquired hepatitis C in childhood. J Pediatr Gastroenterol Nutr (1994) 1.55
Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. J Pediatr Surg (2001) 1.55
High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma. Br Med J (Clin Res Ed) (1982) 1.55
Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology (1993) 1.54
Increased hepatic copper concentration in Indian childhood cirrhosis. Lancet (1979) 1.54
Fulminant hepatic failure in childhood: an analysis of 31 cases. Arch Dis Child (1980) 1.53
Observations on preservation, bile drainage and rejection in 64 human orthotopic liver allografts. Ann Surg (1977) 1.53
N-cadherin and N-CAM in myoblast fusion: compared localisation and effect of blockade by peptides and antibodies. J Cell Sci (1992) 1.52
Spontaneous regression of hepatitis B virus-associated cirrhosis developed in childhood. Dig Liver Dis (2005) 1.51
Clinical course and survival after liver transplantation for hepatitis B virus infection complicated by hepatocellular carcinoma. Am J Gastroenterol (1995) 1.51
Chronic liver disease developing after outbreak of HBsAG-negative hepatitis in haemodialysis unit. Lancet (1975) 1.49
Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut (2003) 1.48
Choledochal cysts: lessons from a 20 year experience. Arch Dis Child (1995) 1.48
Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis. Clin Exp Immunol (1979) 1.47
Orcein-positive liver deposits in Indian childhood cirrhosis. Lancet (1978) 1.47
Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol (1992) 1.46
Familial HBsAg-positive hepatoma: treatment with orthotopic liver transplantation and specific immunoglobulin. Br Med J (1978) 1.46
Interferon-alpha treatment of chronic hepatitis B in childhood: a consensus advice based on experience in European children. J Pediatr Gastroenterol Nutr (1999) 1.45
Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol (1993) 1.43
T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis b virus infection. Gut (1977) 1.42
Detection of HBSAG in fixed liver tissue - use of a modified immunofluorescent technique and comparison with histochemical methods. Gut (1976) 1.42
Seroreversion in human immunodeficiency virus-exposed but uninfected infants. Pediatr Infect Dis J (1995) 1.42
Early cognitive and motor development among infants born to women infected with human immunodeficiency virus. Women and Infants Transmission Study Group. Pediatrics (2000) 1.42
Accelerated development of alcoholic cirrhosis in patients with HLA-B8. Lancet (1982) 1.42
Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group. J Pediatr (1996) 1.41
Halothane-induced acute liver failure: continuing occurrence and use of liver transplantation. Eur J Gastroenterol Hepatol (1998) 1.41
A high index of suspicion: the key to an early diagnosis of Wilson's disease in childhood. J Pediatr Gastroenterol Nutr (1999) 1.41
Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study. AIDS (1998) 1.40
Neck dissection with or without postoperative radiotherapy in supraglottic carcinomas. Otolaryngol Head Neck Surg (1993) 1.40
Chronic hepatitis C in children: a clinical and immunohistochemical comparative study with adult patients. Hepatology (1998) 1.39
Normal venous circulation of the gastroesophageal junction. A route to understanding varices. Gastroenterology (1987) 1.39
Microbial structures in a patient with sporadic non-A, non-B fulminant hepatitis treated by liver transplantation. J Med Virol (1987) 1.39
Changing pattern of alcoholic liver disease in Great Britain: relation to sex and signs of autoimmunity. Br Med J (1977) 1.38
Oral-contraceptive-associated liver tumours: occurrence of malignancy and difficulties in diagnosis. Lancet (1980) 1.37
Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis. J Inherit Metab Dis (2002) 1.37
Budd-Chiari Syndrome: clinical patterns and therapy. Q J Med (1982) 1.37
The prelaparotomy diagnosis of extrahepatic biliary atresia. Arch Dis Child (1983) 1.36
Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives. Br Med J (1975) 1.36
Toga-like virus as a cause of fulminant hepatitis attributed to sporadic non-A, non-B. J Med Virol (1989) 1.34
Mass vaccination against hepatitis B in infants in Italy. Lancet (1988) 1.33
Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis. Hepatology (1983) 1.32
Attachment of Trypanosoma cruzi trypomastigotes to receptors at restricted cell surface domains. Exp Parasitol (1991) 1.31